Global Biopharmaceutical CMO & CRO Market Research Report 2024

Report ID: 1923674 | Published Date: Jan 2025 | No. of Page: 99 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Biopharmaceutical CMO & CRO Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Biologics
        1.2.3 Biosimilars
    1.3 Market by Application
        1.3.1 Global Biopharmaceutical CMO & CRO Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Contract Manufacturing
        1.3.3 Contract Research
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Biopharmaceutical CMO & CRO Market Perspective (2018-2029)
    2.2 Biopharmaceutical CMO & CRO Growth Trends by Region
        2.2.1 Global Biopharmaceutical CMO & CRO Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Biopharmaceutical CMO & CRO Historic Market Size by Region (2018-2023)
        2.2.3 Biopharmaceutical CMO & CRO Forecasted Market Size by Region (2024-2029)
    2.3 Biopharmaceutical CMO & CRO Market Dynamics
        2.3.1 Biopharmaceutical CMO & CRO Industry Trends
        2.3.2 Biopharmaceutical CMO & CRO Market Drivers
        2.3.3 Biopharmaceutical CMO & CRO Market Challenges
        2.3.4 Biopharmaceutical CMO & CRO Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Biopharmaceutical CMO & CRO Players by Revenue
        3.1.1 Global Top Biopharmaceutical CMO & CRO Players by Revenue (2018-2023)
        3.1.2 Global Biopharmaceutical CMO & CRO Revenue Market Share by Players (2018-2023)
    3.2 Global Biopharmaceutical CMO & CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Biopharmaceutical CMO & CRO Revenue
    3.4 Global Biopharmaceutical CMO & CRO Market Concentration Ratio
        3.4.1 Global Biopharmaceutical CMO & CRO Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CMO & CRO Revenue in 2022
    3.5 Biopharmaceutical CMO & CRO Key Players Head office and Area Served
    3.6 Key Players Biopharmaceutical CMO & CRO Product Solution and Service
    3.7 Date of Enter into Biopharmaceutical CMO & CRO Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical CMO & CRO Breakdown Data by Type
    4.1 Global Biopharmaceutical CMO & CRO Historic Market Size by Type (2018-2023)
    4.2 Global Biopharmaceutical CMO & CRO Forecasted Market Size by Type (2024-2029)
5 Biopharmaceutical CMO & CRO Breakdown Data by Application
    5.1 Global Biopharmaceutical CMO & CRO Historic Market Size by Application (2018-2023)
    5.2 Global Biopharmaceutical CMO & CRO Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Biopharmaceutical CMO & CRO Market Size (2018-2029)
    6.2 North America Biopharmaceutical CMO & CRO Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Biopharmaceutical CMO & CRO Market Size by Country (2018-2023)
    6.4 North America Biopharmaceutical CMO & CRO Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Biopharmaceutical CMO & CRO Market Size (2018-2029)
    7.2 Europe Biopharmaceutical CMO & CRO Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Biopharmaceutical CMO & CRO Market Size by Country (2018-2023)
    7.4 Europe Biopharmaceutical CMO & CRO Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Biopharmaceutical CMO & CRO Market Size (2018-2029)
    8.2 Asia-Pacific Biopharmaceutical CMO & CRO Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Region (2018-2023)
    8.4 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Biopharmaceutical CMO & CRO Market Size (2018-2029)
    9.2 Latin America Biopharmaceutical CMO & CRO Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Biopharmaceutical CMO & CRO Market Size by Country (2018-2023)
    9.4 Latin America Biopharmaceutical CMO & CRO Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Biopharmaceutical CMO & CRO Market Size (2018-2029)
    10.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Country (2018-2023)
    10.4 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Lonza
        11.1.1 Lonza Company Detail
        11.1.2 Lonza Business Overview
        11.1.3 Lonza Biopharmaceutical CMO & CRO Introduction
        11.1.4 Lonza Revenue in Biopharmaceutical CMO & CRO Business (2018-2023)
        11.1.5 Lonza Recent Development
    11.2 Boehringer Ingelheim GmbH
        11.2.1 Boehringer Ingelheim GmbH Company Detail
        11.2.2 Boehringer Ingelheim GmbH Business Overview
        11.2.3 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Introduction
        11.2.4 Boehringer Ingelheim GmbH Revenue in Biopharmaceutical CMO & CRO Business (2018-2023)
        11.2.5 Boehringer Ingelheim GmbH Recent Development
    11.3 Rentschler Biotechnologie GmbH
        11.3.1 Rentschler Biotechnologie GmbH Company Detail
        11.3.2 Rentschler Biotechnologie GmbH Business Overview
        11.3.3 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Introduction
        11.3.4 Rentschler Biotechnologie GmbH Revenue in Biopharmaceutical CMO & CRO Business (2018-2023)
        11.3.5 Rentschler Biotechnologie GmbH Recent Development
    11.4 Inno Biologics Sdn Bhd
        11.4.1 Inno Biologics Sdn Bhd Company Detail
        11.4.2 Inno Biologics Sdn Bhd Business Overview
        11.4.3 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Introduction
        11.4.4 Inno Biologics Sdn Bhd Revenue in Biopharmaceutical CMO & CRO Business (2018-2023)
        11.4.5 Inno Biologics Sdn Bhd Recent Development
    11.5 JRS Pharma (Celonic GmbH)
        11.5.1 JRS Pharma (Celonic GmbH) Company Detail
        11.5.2 JRS Pharma (Celonic GmbH) Business Overview
        11.5.3 JRS Pharma (Celonic GmbH) Biopharmaceutical CMO & CRO Introduction
        11.5.4 JRS Pharma (Celonic GmbH) Revenue in Biopharmaceutical CMO & CRO Business (2018-2023)
        11.5.5 JRS Pharma (Celonic GmbH) Recent Development
    11.6 BIOMEVA GmbH
        11.6.1 BIOMEVA GmbH Company Detail
        11.6.2 BIOMEVA GmbH Business Overview
        11.6.3 BIOMEVA GmbH Biopharmaceutical CMO & CRO Introduction
        11.6.4 BIOMEVA GmbH Revenue in Biopharmaceutical CMO & CRO Business (2018-2023)
        11.6.5 BIOMEVA GmbH Recent Development
    11.7 ProBioGen
        11.7.1 ProBioGen Company Detail
        11.7.2 ProBioGen Business Overview
        11.7.3 ProBioGen Biopharmaceutical CMO & CRO Introduction
        11.7.4 ProBioGen Revenue in Biopharmaceutical CMO & CRO Business (2018-2023)
        11.7.5 ProBioGen Recent Development
    11.8 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
        11.8.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Detail
        11.8.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
        11.8.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Introduction
        11.8.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Biopharmaceutical CMO & CRO Business (2018-2023)
        11.8.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Development
    11.9 TOYOBO CO., LTD
        11.9.1 TOYOBO CO., LTD Company Detail
        11.9.2 TOYOBO CO., LTD Business Overview
        11.9.3 TOYOBO CO., LTD Biopharmaceutical CMO & CRO Introduction
        11.9.4 TOYOBO CO., LTD Revenue in Biopharmaceutical CMO & CRO Business (2018-2023)
        11.9.5 TOYOBO CO., LTD Recent Development
    11.10 Samsung BioLogics
        11.10.1 Samsung BioLogics Company Detail
        11.10.2 Samsung BioLogics Business Overview
        11.10.3 Samsung BioLogics Biopharmaceutical CMO & CRO Introduction
        11.10.4 Samsung BioLogics Revenue in Biopharmaceutical CMO & CRO Business (2018-2023)
        11.10.5 Samsung BioLogics Recent Development
    11.11 Patheon
        11.11.1 Patheon Company Detail
        11.11.2 Patheon Business Overview
        11.11.3 Patheon Biopharmaceutical CMO & CRO Introduction
        11.11.4 Patheon Revenue in Biopharmaceutical CMO & CRO Business (2018-2023)
        11.11.5 Patheon Recent Development
    11.12 CMC Biologics
        11.12.1 CMC Biologics Company Detail
        11.12.2 CMC Biologics Business Overview
        11.12.3 CMC Biologics Biopharmaceutical CMO & CRO Introduction
        11.12.4 CMC Biologics Revenue in Biopharmaceutical CMO & CRO Business (2018-2023)
        11.12.5 CMC Biologics Recent Development
    11.13 Binex Co., Ltd.
        11.13.1 Binex Co., Ltd. Company Detail
        11.13.2 Binex Co., Ltd. Business Overview
        11.13.3 Binex Co., Ltd. Biopharmaceutical CMO & CRO Introduction
        11.13.4 Binex Co., Ltd. Revenue in Biopharmaceutical CMO & CRO Business (2018-2023)
        11.13.5 Binex Co., Ltd. Recent Development
    11.14 AbbVie Inc.
        11.14.1 AbbVie Inc. Company Detail
        11.14.2 AbbVie Inc. Business Overview
        11.14.3 AbbVie Inc. Biopharmaceutical CMO & CRO Introduction
        11.14.4 AbbVie Inc. Revenue in Biopharmaceutical CMO & CRO Business (2018-2023)
        11.14.5 AbbVie Inc. Recent Development
    11.15 WuXi Biologics.
        11.15.1 WuXi Biologics. Company Detail
        11.15.2 WuXi Biologics. Business Overview
        11.15.3 WuXi Biologics. Biopharmaceutical CMO & CRO Introduction
        11.15.4 WuXi Biologics. Revenue in Biopharmaceutical CMO & CRO Business (2018-2023)
        11.15.5 WuXi Biologics. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Biopharmaceutical CMO & CRO Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Biologics
    Table 3. Key Players of Biosimilars
    Table 4. Global Biopharmaceutical CMO & CRO Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 5. Global Biopharmaceutical CMO & CRO Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Biopharmaceutical CMO & CRO Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Biopharmaceutical CMO & CRO Market Share by Region (2018-2023)
    Table 8. Global Biopharmaceutical CMO & CRO Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Biopharmaceutical CMO & CRO Market Share by Region (2024-2029)
    Table 10. Biopharmaceutical CMO & CRO Market Trends
    Table 11. Biopharmaceutical CMO & CRO Market Drivers
    Table 12. Biopharmaceutical CMO & CRO Market Challenges
    Table 13. Biopharmaceutical CMO & CRO Market Restraints
    Table 14. Global Biopharmaceutical CMO & CRO Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Biopharmaceutical CMO & CRO Market Share by Players (2018-2023)
    Table 16. Global Top Biopharmaceutical CMO & CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO & CRO as of 2022)
    Table 17. Ranking of Global Top Biopharmaceutical CMO & CRO Companies by Revenue (US$ Million) in 2022
    Table 18. Global 5 Largest Players Market Share by Biopharmaceutical CMO & CRO Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Biopharmaceutical CMO & CRO Product Solution and Service
    Table 21. Date of Enter into Biopharmaceutical CMO & CRO Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Biopharmaceutical CMO & CRO Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Biopharmaceutical CMO & CRO Revenue Market Share by Type (2018-2023)
    Table 25. Global Biopharmaceutical CMO & CRO Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Biopharmaceutical CMO & CRO Revenue Market Share by Type (2024-2029)
    Table 27. Global Biopharmaceutical CMO & CRO Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global Biopharmaceutical CMO & CRO Revenue Market Share by Application (2018-2023)
    Table 29. Global Biopharmaceutical CMO & CRO Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global Biopharmaceutical CMO & CRO Revenue Market Share by Application (2024-2029)
    Table 31. North America Biopharmaceutical CMO & CRO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 32. North America Biopharmaceutical CMO & CRO Market Size by Country (2018-2023) & (US$ Million)
    Table 33. North America Biopharmaceutical CMO & CRO Market Size by Country (2024-2029) & (US$ Million)
    Table 34. Europe Biopharmaceutical CMO & CRO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. Europe Biopharmaceutical CMO & CRO Market Size by Country (2018-2023) & (US$ Million)
    Table 36. Europe Biopharmaceutical CMO & CRO Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Asia-Pacific Biopharmaceutical CMO & CRO Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Region (2018-2023) & (US$ Million)
    Table 39. Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Biopharmaceutical CMO & CRO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Latin America Biopharmaceutical CMO & CRO Market Size by Country (2018-2023) & (US$ Million)
    Table 42. Latin America Biopharmaceutical CMO & CRO Market Size by Country (2024-2029) & (US$ Million)
    Table 43. Middle East & Africa Biopharmaceutical CMO & CRO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Lonza Company Detail
    Table 47. Lonza Business Overview
    Table 48. Lonza Biopharmaceutical CMO & CRO Product
    Table 49. Lonza Revenue in Biopharmaceutical CMO & CRO Business (2018-2023) & (US$ Million)
    Table 50. Lonza Recent Development
    Table 51. Boehringer Ingelheim GmbH Company Detail
    Table 52. Boehringer Ingelheim GmbH Business Overview
    Table 53. Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Product
    Table 54. Boehringer Ingelheim GmbH Revenue in Biopharmaceutical CMO & CRO Business (2018-2023) & (US$ Million)
    Table 55. Boehringer Ingelheim GmbH Recent Development
    Table 56. Rentschler Biotechnologie GmbH Company Detail
    Table 57. Rentschler Biotechnologie GmbH Business Overview
    Table 58. Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Product
    Table 59. Rentschler Biotechnologie GmbH Revenue in Biopharmaceutical CMO & CRO Business (2018-2023) & (US$ Million)
    Table 60. Rentschler Biotechnologie GmbH Recent Development
    Table 61. Inno Biologics Sdn Bhd Company Detail
    Table 62. Inno Biologics Sdn Bhd Business Overview
    Table 63. Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Product
    Table 64. Inno Biologics Sdn Bhd Revenue in Biopharmaceutical CMO & CRO Business (2018-2023) & (US$ Million)
    Table 65. Inno Biologics Sdn Bhd Recent Development
    Table 66. JRS Pharma (Celonic GmbH) Company Detail
    Table 67. JRS Pharma (Celonic GmbH) Business Overview
    Table 68. JRS Pharma (Celonic GmbH) Biopharmaceutical CMO & CRO Product
    Table 69. JRS Pharma (Celonic GmbH) Revenue in Biopharmaceutical CMO & CRO Business (2018-2023) & (US$ Million)
    Table 70. JRS Pharma (Celonic GmbH) Recent Development
    Table 71. BIOMEVA GmbH Company Detail
    Table 72. BIOMEVA GmbH Business Overview
    Table 73. BIOMEVA GmbH Biopharmaceutical CMO & CRO Product
    Table 74. BIOMEVA GmbH Revenue in Biopharmaceutical CMO & CRO Business (2018-2023) & (US$ Million)
    Table 75. BIOMEVA GmbH Recent Development
    Table 76. ProBioGen Company Detail
    Table 77. ProBioGen Business Overview
    Table 78. ProBioGen Biopharmaceutical CMO & CRO Product
    Table 79. ProBioGen Revenue in Biopharmaceutical CMO & CRO Business (2018-2023) & (US$ Million)
    Table 80. ProBioGen Recent Development
    Table 81. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Detail
    Table 82. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
    Table 83. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Product
    Table 84. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Biopharmaceutical CMO & CRO Business (2018-2023) & (US$ Million)
    Table 85. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Development
    Table 86. TOYOBO CO., LTD Company Detail
    Table 87. TOYOBO CO., LTD Business Overview
    Table 88. TOYOBO CO., LTD Biopharmaceutical CMO & CRO Product
    Table 89. TOYOBO CO., LTD Revenue in Biopharmaceutical CMO & CRO Business (2018-2023) & (US$ Million)
    Table 90. TOYOBO CO., LTD Recent Development
    Table 91. Samsung BioLogics Company Detail
    Table 92. Samsung BioLogics Business Overview
    Table 93. Samsung BioLogics Biopharmaceutical CMO & CRO Product
    Table 94. Samsung BioLogics Revenue in Biopharmaceutical CMO & CRO Business (2018-2023) & (US$ Million)
    Table 95. Samsung BioLogics Recent Development
    Table 96. Patheon Company Detail
    Table 97. Patheon Business Overview
    Table 98. Patheon Biopharmaceutical CMO & CRO Product
    Table 99. Patheon Revenue in Biopharmaceutical CMO & CRO Business (2018-2023) & (US$ Million)
    Table 100. Patheon Recent Development
    Table 101. CMC Biologics Company Detail
    Table 102. CMC Biologics Business Overview
    Table 103. CMC Biologics Biopharmaceutical CMO & CRO Product
    Table 104. CMC Biologics Revenue in Biopharmaceutical CMO & CRO Business (2018-2023) & (US$ Million)
    Table 105. CMC Biologics Recent Development
    Table 106. Binex Co., Ltd. Company Detail
    Table 107. Binex Co., Ltd. Business Overview
    Table 108. Binex Co., Ltd. Biopharmaceutical CMO & CRO Product
    Table 109. Binex Co., Ltd. Revenue in Biopharmaceutical CMO & CRO Business (2018-2023) & (US$ Million)
    Table 110. Binex Co., Ltd. Recent Development
    Table 111. AbbVie Inc. Company Detail
    Table 112. AbbVie Inc. Business Overview
    Table 113. AbbVie Inc. Biopharmaceutical CMO & CRO Product
    Table 114. AbbVie Inc. Revenue in Biopharmaceutical CMO & CRO Business (2018-2023) & (US$ Million)
    Table 115. AbbVie Inc. Recent Development
    Table 116. WuXi Biologics. Company Detail
    Table 117. WuXi Biologics. Business Overview
    Table 118. WuXi Biologics. Biopharmaceutical CMO & CRO Product
    Table 119. WuXi Biologics. Revenue in Biopharmaceutical CMO & CRO Business (2018-2023) & (US$ Million)
    Table 120. WuXi Biologics. Recent Development
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biopharmaceutical CMO & CRO Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Biopharmaceutical CMO & CRO Market Share by Type: 2022 VS 2029
    Figure 3. Biologics Features
    Figure 4. Biosimilars Features
    Figure 5. Global Biopharmaceutical CMO & CRO Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 6. Global Biopharmaceutical CMO & CRO Market Share by Application: 2022 VS 2029
    Figure 7. Contract Manufacturing Case Studies
    Figure 8. Contract Research Case Studies
    Figure 9. Biopharmaceutical CMO & CRO Report Years Considered
    Figure 10. Global Biopharmaceutical CMO & CRO Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 11. Global Biopharmaceutical CMO & CRO Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 12. Global Biopharmaceutical CMO & CRO Market Share by Region: 2022 VS 2029
    Figure 13. Global Biopharmaceutical CMO & CRO Market Share by Players in 2022
    Figure 14. Global Top Biopharmaceutical CMO & CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO & CRO as of 2022)
    Figure 15. The Top 10 and 5 Players Market Share by Biopharmaceutical CMO & CRO Revenue in 2022
    Figure 16. North America Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 17. North America Biopharmaceutical CMO & CRO Market Share by Country (2018-2029)
    Figure 18. United States Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 19. Canada Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. Europe Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Europe Biopharmaceutical CMO & CRO Market Share by Country (2018-2029)
    Figure 22. Germany Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. France Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. U.K. Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Italy Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Russia Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Nordic Countries Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Asia-Pacific Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Asia-Pacific Biopharmaceutical CMO & CRO Market Share by Region (2018-2029)
    Figure 30. China Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Japan Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. South Korea Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Southeast Asia Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. India Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Australia Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Latin America Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Latin America Biopharmaceutical CMO & CRO Market Share by Country (2018-2029)
    Figure 38. Mexico Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Brazil Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Middle East & Africa Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Middle East & Africa Biopharmaceutical CMO & CRO Market Share by Country (2018-2029)
    Figure 42. Turkey Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Saudi Arabia Biopharmaceutical CMO & CRO Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Lonza Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2018-2023)
    Figure 45. Boehringer Ingelheim GmbH Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2018-2023)
    Figure 46. Rentschler Biotechnologie GmbH Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2018-2023)
    Figure 47. Inno Biologics Sdn Bhd Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2018-2023)
    Figure 48. JRS Pharma (Celonic GmbH) Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2018-2023)
    Figure 49. BIOMEVA GmbH Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2018-2023)
    Figure 50. ProBioGen Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2018-2023)
    Figure 51. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2018-2023)
    Figure 52. TOYOBO CO., LTD Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2018-2023)
    Figure 53. Samsung BioLogics Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2018-2023)
    Figure 54. Patheon Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2018-2023)
    Figure 55. CMC Biologics Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2018-2023)
    Figure 56. Binex Co., Ltd. Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2018-2023)
    Figure 57. AbbVie Inc. Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2018-2023)
    Figure 58. WuXi Biologics. Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2018-2023)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Lonza
Boehringer Ingelheim GmbH
Rentschler Biotechnologie GmbH
Inno Biologics Sdn Bhd
JRS Pharma (Celonic GmbH)
BIOMEVA GmbH
ProBioGen
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
TOYOBO CO., LTD
Samsung BioLogics
Patheon
CMC Biologics
Binex Co., Ltd.
AbbVie Inc.
WuXi Biologics.
Frequently Asked Questions
Biopharmaceutical CMO & CRO report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biopharmaceutical CMO & CRO report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biopharmaceutical CMO & CRO report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Bonded Carbide

This report aims to provide a comprehensive presentation of the global market for Bonded Carbide, ... Read More